You can watch OTLKW and buy or sell other stocks, options, and ETFs commission-free!
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ. The listed name for OTLKW is Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022.
Lawrence A. Kenyon, CPA
South Brunswick, New Jersey
52 Week High
52 Week Low